scholarly journals Pharmacokinetics, Safety, and Tolerability of NPC‐21, an Anti‐Cytomegalovirus Monoclonal Antibody, in Healthy Japanese and White Adult Men: A Randomized, Placebo‐Controlled, First‐in‐Human Phase 1 Study

2022 ◽  
Author(s):  
Kenichi Furihata ◽  
Izumi Hamada ◽  
Takuro Niwa ◽  
Tatsuya Watanabe ◽  
Sachiko Ezoe
Keyword(s):  
Monoclonal Antibody ◽  
Phase 1 ◽  
Phase 1 Study ◽  
Adult Men

scholarly journals Phase 1 study of MEDI0562, a humanized OX40 agonist monoclonal antibody (mAb), in adult patients (pts) with advanced solid tumors

2016 ◽  
Vol 27 ◽  
pp. vi361 ◽  
Author(s):  
B.S. Glisson ◽  
R. Leidner ◽  
R.L. Ferris ◽  
J. Powderly ◽  
N. Rizvi ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Solid Tumors ◽  
Phase 1 ◽  
Adult Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study

scholarly journals A Phase 1 Study of Necitumumab (Anti-Egfr Monoclonal Antibody) in Japanese Patients with Advanced Solid Tumors

2014 ◽  
Vol 25 ◽  
pp. v70 ◽  
Author(s):  
Hiroshi Nokihara ◽  
Noboru Yamamoto ◽  
Yosuke Tamura ◽  
Yuko Tanabe ◽  
Kazunori Honda ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study

Abstract 2506: A phase 1 study of ABT-806, a humanized recombinant anti-EGFR monoclonal antibody, in patients with advanced solid tumors

2012 ◽  
Author(s):  
James M. Cleary ◽  
Lorrin Kwock-Chong Yee ◽  
Nilofer Azad ◽  
Michael Carducci ◽  
David Cosgrove ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Solid Tumors ◽  
Phase 1 ◽  
Advanced Solid Tumors ◽  
Phase 1 Study

Phase 1 study of an anti-GD3 monoclonal antibody, (KW-2871) in patients with advanced metastatic melanoma

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 2556-2556
Author(s):  
J. Shah ◽  
A. Forero ◽  
R. Carlisle ◽  
P. Triozzi ◽  
A. Lobuglio ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Metastatic Melanoma ◽  
Phase 1 ◽  
Phase 1 Study
Sign in / Sign up

Export Citation Format

Share Document